Antimycotic Activity Potentiation of Allium sativum Extract and Silver Nanoparticles against Trichophyton rubrum

Chem Biodivers. 2019 Apr;16(4):e1800525. doi: 10.1002/cbdv.201800525. Epub 2019 Mar 5.

Abstract

A natural and biocompatible extract of garlic as a support, decorated with silver nanoparticles, is a proposal to generate an effective antifungal agent against dermatophytes at low concentrations. Silver nanoparticles (AgNPs) with a diameter of 26±7 nm were synthesized and their antimycotic activity was examined against Trichophyton rubrum (T. rubrum), inhibiting 94 % of growth at a concentration of 0.08 mg ml-1 . Allium sativum (garlic) extract was also obtained (AsExt), and its MIC was 0.04 mg ml-1 . To increase the antifungal capacity of those systems, AsExt was decorated with AgNPs, obtaining AsExt-AgNPs. Using an AsExt concentration of 0.04 mg ml-1 in independent experiments with concentrations from 0.01 to 0.08 mg ml-1 of AgNPs, it was possible to inhibit T. rubrum at all AgNPs concentrations; it proves a synergistic effect between AgNPs and AsExt. Even if 1 % of the minimum inhibitory concentration of AsExt (0.0004 mg ml-1 ) is used, it was possible to inhibit T. rubrum at all concentrations of AgNPs, demonstrating the successful antimycotic activity potentiation when combining AsExt and AgNPs.

Keywords: Allium sativum (garlic); Trichophyton rubrum; antimycotic activity; biological activity; potentiation; silver nanoparticles.

MeSH terms

  • Antifungal Agents / chemistry
  • Antifungal Agents / isolation & purification
  • Antifungal Agents / pharmacology*
  • Dose-Response Relationship, Drug
  • Garlic / chemistry*
  • Microbial Sensitivity Tests
  • Molecular Structure
  • Nanoparticles / chemistry*
  • Plant Extracts / chemistry
  • Plant Extracts / isolation & purification
  • Plant Extracts / pharmacology*
  • Silver / chemistry
  • Silver / pharmacology*
  • Structure-Activity Relationship
  • Trichophyton / drug effects*

Substances

  • Antifungal Agents
  • Plant Extracts
  • Silver

Grants and funding